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ox2u-GIobuIin Nephropathy: Review of the
Cellular and Molecular Mechanisms lnvolved
and Their Implicaions for Human Risk
Assessment
by James A. Swenberg
This paper reviews what is known about the induction of (x.u-globulin nephropathy and carcinogenesis. This
unique male-rat-specific disease is associated with exposure to an ever-increasing number of chemicals. The
processes leading to nephropathy and renal cancer are among the best-understood mechanisms for non-
genotoxic chemicals and strongly support that it is a male-rat-specific process that is not relevant for human
risk assessment. Nevertheless, the data available for individual chemicals vary greatly. This necessitates a
case-by-case analysis of the available data when determining the relevance for humans of this chemically
induced renal disease in male rats.
Introduction
After the discovery that unleaded gasoline (UG) caused
kidney tumors in male rats but not in female rats or either
sex of mice, a series of studies was undertaken to under-
stand this sex- and species-specific disease. Investigations
by Halder et al. demonstrated the formation of protein
droplet nephropathy by a series of branched aliphatic
hydrocarbons (1,2). One of the most potent hydrocarbons
causing this disease wAas 2,2,4-trimethylpentane (TMP),
an important component of gasoline. The suggestion that
hydrocarbon nephropathy might be related to the male-
rat-specific protein, "2,,-globulin (X2,,) was first made by
Alden, who identified ox92 as the accumulating protein in
male rats exposed to decatin and hypothesized that a
similar phenomenon might occur with other hydrocarbons
(3,4). Since these early studies, many additional chemicals
have been shown to cause a2xz nephropathy in male rats.
None of these have caused a similar nephropathy in female
rats or either sex of any other species (5-7). Thus, 2>,,
nephropathy appears to represent a sex- and species-
specific disease.
u2Xu Nephropathy is characterized by the accumulation
of protein droplets in the P2 segment of the proximal
tubule, subsequent single cell necrosis, the formation of
granular casts at the junction of the proximal tubule and
the thin loop of Henle, and the presence of regenerative
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tubules. With chronic exposure, there is a progression of
these lesions, the formation of linear mineralization in the
renal medulla, and an exacerbation of chronic progressive
nephropathy, the spontaneous nephropathy of aging rats.
Chronic exposure of male rats to UG and numerous other
nongenotoxic chemicals also led to the formation of
exposure-related increases in renal tumors. The incidence
of tubular neoplasms of the kidney induced by agents
causing %,,1 nephropathy ranged from 0 to 26%. This is
markedly different from the induction of renal tumors by
known genotoxic agents, which frequently reaches 100%
(8). The chemicals known to cause this °t2, nephropathy are
listed in Table 1.
The protein 2tix is a well-characterized, low moleculai
weight protein of 18,700 D that is synthesized in the liver of
male rats under androgenic control, secreted into the
plasma, and freely filtered by the glomerulus (9,10).
Approximately half of the (X2u present in the glomerular
filtrate is resorbed by the P2 segment of the proximal
tubule of the nephron, and the other half is excreted in the
urine (11,12). Tubular resorption of U2,, occurs via
endocytosis. The endosomes then fuse with primary lyso-
somes, where the protein undergoes hydrolytic digestion.
Whereas large amounts of protein are found in the urine
ofmale rats, U2u is found in the urine offemale and sexually
immature rats at concentrations that are less than 1/100
that found in young adult males (13,14). Hepatic synthesis
accounts for most of the o2u in male rats, with synthesis
beginning at the onset of sexual maturity and increasing
to 20 weeks of age, after which it plateaus and then begins
to decline with increasing age (15). Female rats do not
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Table 1. Data sets for chemicals causing ox,u-globulin nephropathy (7).
Pirotein Incrieased Cell Initiation/
Substance/chemical droplets Qx.,,I Binding plroliferation pr omotion
d-Limonene + + + + +
Unleaded gasoline + + + + +
2,2,4-nTimethylpentane + + + + +
1,4-Dichloirobenzene + + + + NR
Isophorone + + + + NR
3,5,5-Trimethyl hexanoic acid derivatives + + + NR NR
Decalin + + NR +± NR
Tetrachloroethvlene + + NR + NR
Pentachloroethane + + NR + NR
CIO0-C,2 isopar affinic solvent
(saturated aliphatic hydrocarbons) + + NR NR NR
Lindane + + NR NR NR
BW540C + + NR NR NR
BW58C + + NR NR NR
Levamisole + + NR NR NR
Gabapentin + + NR NR NR
Tridecyl acetate + + NR NR NR
Isopropylcyclohexane + + NR NR NR
JP-5 jet fuel (mixed distillate hydrocarbons) + NR NR NR NR
JP-4 jet fuel (mixed distillate hydrocarbons) + NR NR NR NR
Diesel, fuel maline + NR NR NR NR
JP-1O synthetic jet fuel (exohexahydro-4,7-
methanoindan) + NR NR NR NR
RJ-5 synthetic jet fuel (hydrogenated dimers
of norbornadiene) + NR NR NR NR
JP-7 distillate jet fuel + NR NR NR NR
JP-TS dlistillate jet fuel + NR NR NR NR
Stod(daid solvent + NR NR NR NR
Tetralin + NR NR NR NR
Hexachloiroethane + NR NR NR NR
Dimethyl methylphosphonate + NR NR NR NR
Methyl isobutyl ketone + NR NR NR NR
Methyl isoamyl ketone + NR NR NR NR
Diisobutyl ketone + NR NR NR NR
1,3,6-Tricyanohexane + NR NR NR NR
NR, not reported.
'Based on cell counts from urine.
synthesize Ot2U in the liver but do synthesize small amounts
of the protein in the salivary gland.
Cellular and Molecular Mechanisms
of t2u Nephropathy
An early hypothesis for an association between ox21 and
UG in the induction of the male-rat-specific nephropathy
and associated carcinogenicity was that TMP and related
hydrocarbons were being metabolized to their respective
aldehydes, which formed a Schiffs base and covalently
bound to U2ii (16). Whole-body autoradiographs after
administration of [14C] TMP demonstrated selective
retention of radioactivity in the renal cortex of male but
not female rats (16). Likewise, kidney cytosol contained
prominent amounts of labeled TMP that exhibited a
supralinear dose response, while no accumulation was
evident in female kidney or in liver of either sex (16).
Subsequent experiments demonstrated that the observed
binding was not covalent, however (17). If kidney cytosol
from male rats administered [14C] TMP was separated by
G75 Sephadex chromatography, the radioactivity coeluted
with the low molecular weight protein fraction and free
metabolites. If the cytosol was first dialyzed against phos-
phate buffer, radioactivity only coeluted with the low
molecular weight proteins. When the protein denaturing
detergent, sodium dodecyl sulfate, was added to the
dialysis buffer, the radioactivity associated with the low
molecular weight protein fraction was lost. These experi-
ments demonstrated that the binding between the low
molecular protein fractions and TMP was reversible, not
covalent (17). Immunoassay of the same low molecular
weight protein chromatography fractions demonstrated
the presence of a2u. These fractions were collected,
extracted with acidified ethyl acetate, and analyzed by gas
chromatography-mass spectrometry to identify the bound
material. The reversibly bound metabolite of TMP was
identified as 2,4,4-trimethyl-2-pentanol (TMPOH). Subse-
quent experiments exposed male F344 rats to 50 ppm TMP
or 300 ppm UG and demonstrated thatTMPOH was bound
to 0L2u (18).
Reversible binding to x2u has been demonstrated for at
least 13 chemicals in in vitro or in vivo studies (17,19-21).
Even though the agents fall into rather diverse chemical
classes, molecular modeling studies have demonstrated
strong structure-activity relationships (22). Active chemi-
cals fit deeply into a hydrophobic pocket of o2uL. When
hydrogen bonding between the chemical and protein can
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occur, the digestibility of (X2U by proteases is inhibited,
leading to accumulation of the male-rat-specific protein in
lysosomes of the P2 segment of the nephron (23).
The accumulation of t2u iS cytotoxic and results in
single-cell necrosis (24-26). The exfoliated renal epi-
thelium, which represents the nidus for granular cast
formation, is restored by compensatory cell proliferation.
This increase in cell proliferation is localized in the P2
segment of the nephron and to a much lesser extent in the
P3 segment (25,27,28). Increased cell proliferation can be
readily demonstrated using pulse (27) or continuous (25-
26,28) administration of [3H]-thymidine or bromodeox-
yuridine, can be detected as early as 3 days after exposure
to t2u-inducing agents, and has been demonstrated to
remain elevated through at least 50 weeks of exposure to
UG (25). The increase in proliferation is dose related, with
maximum tolerated doses (MTD) resulting in 5- to 12-fold
greater numbers of labeled cells (25,28). Clear, no-effect
doses have been demonstrated (25,27,28). Of great impor-
tance is the demonstration that kidneys of female rats that
have been identically exposed to UG have no increase in
cell proliferation (25). While this strongly suggests that
the increase in cell proliferation requires the presence of
large amounts of at2U, a recent study comparing cell pro-
liferation in d-limonene exposed F344 versus NBR male
rats has shown that the protein is absolutely required (26).
The NBR rat is the only identified strain of rat that does
not synthesize the androgen-dependent form of u2u (29).
Whereas the F344 rats exposed to d-limonene exhibited a
5-fold increase in cell proliferation after 5 or 30 weeks of
exposure to 150 mg/kg/day, NBR rats were unaffected
(26). Both strains metabolized d-limonene to the 1,2-oxide,
the nonmutagenic metabolite that reversibly binds to t2u
(21,26,30). The increase in cell proliferation associated
with Ot2u nephropathy is reversible. After exposures of up
to 3 weeks to TMP or UG, proliferation returns to control
rates within 1 week after cessation of exposure (25).
Longer-term exposures result in a slower return to control
rates. Morphologic evidence of regenerative tubules can
still be identified 4 weeks after subchronic exposure ceases
(1,2).
This sustained increase in cell proliferation is capable of
promoting spontaneously initiated or chemically initiated
cells of the proximal tubule to form preneoplastic and
neoplastic lesions (26,31). The promoting activity is totally
dependent on the presence of a2,. When F344 rats were
exposed to UG or TMP in an initiation-promotion study,
concentration-related increases in preneoplastic and neo-
plastic renal lesions were evident in males initiated with
ethylhydroxyethylnitrosamine (EHEN) and promoted
with UG or TMP (31). No increases occurred in females.
The promoting activity paralleled increases in cell pro-
liferation (25). When NBR rats were initiated with EHEN
and promoted with d-limonene, no increase in atypical
tubules, atypical hyperplasia, or renal adenomas occurred
(26). In contrast, F344 rats promoted with d-limonene
developed increased numbers of atypical tubules and
atypical hyperplasia, while F344 rats initiated with
EHEN and promoted with d-limonene developed
increased numbers of atypical tubules, atypical hyper-
plasias, and renal adenomas (26). Promotion ofpreneoplas-
tic or neoplastic lesions only occurred in groups that also
exhibited increased cell proliferation. An important obser-
vation from this study was the presence of occasional
preneoplastic lesions in the kidneys of control rats of both
strains, as these lesions are thought to represent precur-
sors of spontaneous kidney tumors. The incidence of these
lesions was increased by exposure to EHEN in both
strains and by exposure to d-limonene alone in male F344
rats. These data strongly suggest that agents that cause
t2u nephropathy, such as UG, induce renal tumors in male
rats through sustained increases in cell proliferation. The
higher rate of cell proliferation decreases the amount of
time available to repair DNA damage, increasing the
probability of mutations leading to spontaneously initiated
renal epithelial cells and promoting clonal expansion of
such cells, thereby increasing the probability of neoplasia
(32,33).
Additional evidence for the sex and species specificity of
this syndrome comes from studies on levamisole.
Levamisole, a drug used as an antihelminthic in cancer
chemotherapy and in the treatment of rheumatoid
arthritis in humans, causes a2u nephropathy in male rats
(34). No increase in urinary N-acetyl 3-glucosaminidase,
an indicator of nephrotoxicity, was present in patients
receiving 150 mg levamisole per day for 26 weeks (35).
Levamisole has not been studied yet for carcinogenicity in
animals or humans.
Several of the chemicals that induce oL2u-related male rat
kidney tumors also cause tumors in mouse liver. 1,4-
Dichlorobenzene, isophorone, pentachloroethane, tetra-
chloroethylene, and UG represent such examples (36-41).
The mechanism responsible for the induction of liver
tumors is not definitively known at this time. Marked
decreases in uterine cystic hyperplasia and uterine involu-
tion were apparent in the high-dose group of the UG
mouse carcinogenicity bioassay but not in the middle- or
low-dose groups (42). This suggests that the hormonal
status of the high-dose female mice was affected by expo-
sure to UG. It is well documented that either castration or
administration of testosterone to female mice increases
the incidence of hepatic neoplasia (43). Thus, the increased
incidence of hepatic tumors in the UG mouse bioassay may
have been due to a secondary mechanism that does not
extrapolate to low exposures. Additional research will be
necessary to further delineate the role of hormonal altera-
tion for UG and the other chemicals known to cause t2u
nephropathy and female mouse liver tumors.
Not all agents that induce °t2u nephropathy have
resulted in an increased incidence ofkidney tumors in male
rats. In some cases, this has been due to an inadequate
length of exposure. For example, a series of hydrocarbons
was evaluated in rats exposed for 90 days and held for an
additional 19 months (44,45). None of the hydrocarbons
caused increases in renal tumors. When rats were exposed
to the same hydrocarbons for 1 or more years, tumors were
induced in the kidneys of male rats. An antiepileptic agent
has recently been shown to induce a2u nephropathy in
Wistar rats, but it did not induce renal neoplasia (46).
Although a2u was demonstrated immunohistochemically,
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no information on binding, cell proliferation, or initiation!
promotion is available. The incidence of renal tumors
induced by the (.2. mechanism is much lower (0-26%) than
can be achieved by genotoxic renal carcinogens admin-
istered at their maximum tolerated dose (8). Furthermore,
the extent of mechanistic research available for different
agents varies markedly (Table 1). Thus, although the
weight of evidence available for this class of agents sup-
porting this sex- and species-specific mechanism is very
strong, determination of the relevance of this mechanism
for a specific chemical's carcinogenic activity requires a
case-by-case analysis.
Species Differences in Urinary Protein
Having established that the presence of CX2u is manda-
tory for the formation of male-rat kidney tumors after
treatment with a2 nephropathy-inducing agents, the
question arises whether extrapolation of such carcino-
genicity data to other species, including humans, is war-
ranted. Most compounds that are carcinogenic in animals
are generally assumed to pose somne risk to humans. In the
case of ot2, nephropathy-inducing agents, however, the
carcinogenic mechanism is clerly associated with the
presence of a specific urinary protein (%u) not found in
humans or any other species. Several proteins sharing
some amino acid sequenee homology with %2u have been
identified in the serum and urine ofvarious species, includ-
ing humans (47-50). The presence of these partially
homologous proteins in humans raised coneern as to the
possible interaction of these low niolecular weight proteins
with U2u nephropathy-inducing agents, th-us questioning
the male-rat specificity of (x2, nephropathy. Assuming that
a homologous protein reversibly binds the previously men-
tioned chemicals, the protein needs to be excreted into the
plasma in large amounts, freely filtered by the glomerulus,
readily reabsorbed in the proximal tubules, and cata-
bolized in the lysosomes of the proximal tubule epithelial
cells at a slower rate than normal upon binding one of the
chemicals in order to induce similar lesions to 02U
nephropathy.
Based on estimated daily average urine production and
body weights of rats and humai-s, Olsan et al. (51) showed
that rats excrete approximately 90 times more total pro-
tein than humans. Of the total protein excreted, the pre-
dominant fraction in rats consisted of low molecular
weight proteins (18 kD), whereas a predominance of high
molecular weight proteins (66 kD) was found in humans.
The small amount of low molecular weight proteins
excreted by male humans was identified as -1-acid
glycoprotein, ol-microglobulin, myoglobin, and 02-
microglobulin. Of these four proteins, only o1-acid
glycoprotein and xl-microglobulin share amino acid
sequence homology with o2u (47,48,50). al-Acid glyeopro-
tein (AGP) and col-microglobulin (AMG) are synthesized in
the liver of rats and humans (50,52-54), have been purified
from the urine of rats and humans, as well as the urine of
rabbits and guinea pigs in the case of AMG (48,54), and,
thus, permit a direct comparison with o2u-
If AGP and AMG reversibly bind 2u nephropathy-
inducing chemicals and/or their metabolites with the same
affinity as o2u, then one would expect that female rats,
male NBR rats, rabbits, and guinea pigs would also
develop renal disease after treatment with these chemi-
cals. However, male NBR rats, female rats, and guinea pigs
do not accumulate protein in the renal cortex after treat-
ment with 2u nephropathy-inducing agents and, thus, are
refractory to this disease (5,27,55,56-60) Furthermore,
several members of the superfamily, including AGP, have
been shown not to bind a2%-inducing metabolites (61) In
addition, mice, which excrete comparable amounts of the
low molecular weight mouse urinary protein (MUP) hav-
ing the greatest amino acid sequence homology to a2u
(approximately 90%) (6), do not develop the protein-related
nephropathy or renal tumors after chronic exposure to ot2U
nephropathy inducing agents (36,39-41,62-43). Lehman-
McKeeman et al. demonstrated that the lack of respon-
siveness of the mouse is due to a lack of cX2u nephropathy-
inducing metabolites to bind to MUP and the lack ofMUP
resorption by mouse renal tubules (64)
Recently, a sex-linked human protein of similar size was
identified in urine from patients with renal disease (65,66).
This protein has been named urine protein 1 and has been
called the human equivalent of at2u (65). This reference has
led to considerable confusion and miscitation. Jackson and
Turner (67) purified and partially sequenced human urine
protein 1 and determined that it is related to rabbit uter-
oglobin, not a-2u. Urine protein 1 does not bind d-limonene-
1,2-oxide or 2,4,4-trimethyl-2-pentanol, two metabolites of
chemicals that bind X a (61). Urine protein 1 also is
present in human urine at concentrations four to five orders
of magitude less that that of a2u in male rat urine (7).
Conclusions
A detailed understanding of the mechanisms involved in
ot2u nephropathy and renal careinogenesis has been eluci-
dated by investigating several chemicals in various animal,
biochemical, and molecular modeling systems. All of the
experimental data are consistent with the hypothesis that
reversible binding ofchemicals or their metabolites to this
abundant male-rat-specific protein is causally related to
the induction of disease. Our present understanding of
this disease process strongly suggests that it is unlikely
that nongeno-toxic chemicals that have been shown to only
induce renal tumors in male rats via this mechanism pose a
carcinogenic risk to humans.
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